387 related articles for article (PubMed ID: 15143368)
1. Immunoglobulins and complement components in patients with lung cancer.
Oner F; Savaş I; Numanoğlu N
Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins and complement components levels in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and IL-2R in lung cancer.
Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
[TBL] [Abstract][Full Text] [Related]
4. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
5. Association of serum C3 levels with the risk of myocardial infarction.
Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
Li R; Li R; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
[TBL] [Abstract][Full Text] [Related]
7. [Levels of complement components in plasma of onco-hematologic patients with defective hemopoiesis].
Rybakova LP; Tiagotin IV; Ganapiev AA; Moiseev SI; Ushakova EA; Abdulkadyrov KM; Ishchenko AM
Vopr Onkol; 1996; 42(2):63-7. PubMed ID: 8815636
[TBL] [Abstract][Full Text] [Related]
8. The immunoglobulin and complement levels in the active pulmonary sarcoidosis.
Cagatay T; Bilir M; Gulbaran M; Papila C; Cagatay P
Kobe J Med Sci; 2003; 49(5-6):99-106. PubMed ID: 15141145
[TBL] [Abstract][Full Text] [Related]
9. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.
Kinsella TD; Espinoza L; Vasey FB
J Rheumatol; 1975 Sep; 2(3):308-13. PubMed ID: 1185743
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with colorectal cancer.
Tsavaris N; Tsigalakis D; Bobota A; Tsoutsos E; Sarafidou M; Papazachariou M; Komitsopoulou P; Kosmidis P
Eur J Surg Oncol; 1992 Feb; 18(1):31-6. PubMed ID: 1737590
[TBL] [Abstract][Full Text] [Related]
11. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer.
Moulas AN; Gerogianni IC; Papadopoulos D; Gourgoulianis KI
Respirology; 2006 Mar; 11(2):169-74. PubMed ID: 16548902
[TBL] [Abstract][Full Text] [Related]
12. Complement and immunoglobulin levels in Ilorin Nigeria, and environ.
Oyeyinka GO; Aiyedun BA; Erasmus RT; Adewoye HO; Adetoro OO; Adedoyin MA
Afr J Med Med Sci; 1995 Mar; 24(1):9-16. PubMed ID: 7495207
[TBL] [Abstract][Full Text] [Related]
13. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
14. Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.
Srivastava LM; Agarwal DP; Goedde HW; Rohde R
Tropenmed Parasitol; 1975 Jun; 26(2):212-8. PubMed ID: 1162738
[TBL] [Abstract][Full Text] [Related]
15. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
Kanoh Y; Ohara T; Mashiko T; Abe T; Masuda N; Akahoshi T
Anticancer Res; 2006; 26(6B):4293-7. PubMed ID: 17201147
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of some immunological parameters in pulmonary tuberculosis].
Dubaniewicz A; Sztaba-Kania M; Hoppe A
Pol Merkur Lekarski; 2004 Feb; 16(92):123-7. PubMed ID: 15176294
[TBL] [Abstract][Full Text] [Related]
18. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
20. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
Gencer M; Ceylan E; Aksoy N; Uzun K
Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
